• The New Money
  • Posts
  • Nuclear Fuel Breakthroughs, Bitcoin Options Trading, And Applying Neuroscience And AI To Clinical Data

Nuclear Fuel Breakthroughs, Bitcoin Options Trading, And Applying Neuroscience And AI To Clinical Data

The markets and trends that matter, made simple. Discover what’s next.

Oklo Is Getting Closer To Officially Fabricating Nuclear Fuel

Oklo (NYSE: OKLO) has received an approval from the United States Department of Energy on their Conceptual Safety Design Report for the Aurora Fuel Fabrication Facility located at the Idaho National Laboratory. Most nuclear reactors are unable to use the vast majority of the energy content that exists in their fuel, which Oklo’s reactors are aiming to completely change by turning used fuel waste into clean energy.

Bitcoin Options Trading Is Coming To The Big Leagues

The United States Securities and Exchange Commission has granted approval to both the New York Stock Exchange and Cboe Exchange to allow options trading on spot Bitcoin ETFs in a move that is likely to further accelerate overall liquidity and institutional participation.

Firefly Neuroscience and Bright Minds Biosciences Collaborate On Clinical Trial Data

Firefly Neuroscience (NASDAQ: AIFF) has announced a collaboration with Bright Minds Biosciences (NASDAQ: DRUG) to leverage their proprietary neuroscience technology for analyzing new data from a Phase I clinical trial of Bright Minds Bioscience’s lead compound BMB-101. Notably, Bright Minds’ share price was up over 3,500% this week alone.

The Sprint

The Markets This Week

+99.2% | Oklo Inc. (NYSE: OKLO). Backed by OpenAI Founder Sam Altman, Oklo’s fast fission technology is catching the attention of investors amidst big tech’s new obsession with nuclear energy.

+33.1% | GameSquare Holdings (NASDAQ: GAME). The public company backed by Dallas Cowboys owner Jerry Jones recently expanded their partnership with popular online crypto casino operator Rollbit.

+29.3% | Firefly Neuroscience (NASDAQ: AIFF) is leveraging artificial intelligence and machine learning technology to unlock a much better understanding of drug development for biotechnology companies, such as their collaboration this week with Bright Minds.

+24.7% | IonQ (NYSE: IONQ) was recently awarded a new $54.5 million contract from the United States Air Force Research Lab to design and deploy technology and hardware that can be used for quantum systems.

+24.6% | TeraWulf (NASDAQ: WULF). The company backed by legendary investor Stanley Druckenmiller sold their minority interest in the Nautilus Bitcoin mining property located in Pennsylvania earlier this month to Talen Energy (NASDAQ: TLN) for $85 million in cash.

+24.4% | Soluna Holdings (NASDAQ: SLNH) previously began construction of their new data centre located in Texas that is powered entirely by excess renewable energy generated by a nearby wind farm.

+18.8% | Byrna Technologies (NASDAQ: BYRN) recently announced their largest quarterly revenue in company history for their less lethal weapons.

Looking to connect? Reach out and get in touch.

New here? Join our community of 30,000+ individuals interested in uncovering the world’s most exciting early stage companies.

Disclaimer: The New Money provides background information on early stage companies from publicly available sources. The New Money provides no advice on dealing in securities, is not a financial adviser and does not pretend to be so. This message is meant for information and educational purposes only. The information contained in this email is not to be considered factual or complete. Anybody interested in obtaining financial and other information on companies mentioned is advised to get it direct from the companies, or from their own investment adviser. The New Money does not intend for this information to be used to inform an investment decision. The New Money has been compensated by some of the companies mentioned in this email for awareness campaigns, which affects our ability to be unbiased. The Principals of The New Money may buy or sell shares of the mentioned companies without further notice. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities. The New Money and its principals and agents are not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Always do your own research and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment. Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy or Sell securities. No representation is being made that any stock trade will or is likely to achieve profits. Comparisons made to other featured companies or past performance is not indicative of future results.